← Open Payments lookup

CHRISTINE HALL: Open Payments

NPI 1205305125 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$575 in 16 payments from 6 companies in 2025. Trend: 2023 $168 · 2024 $168 · 2025 $575

Food & beverage: $575
CompanyPaymentsAmount
Xeris Pharmaceuticals, Inc.2$235
ABBVIE INC.5$131
Solventum Corporation3$81
Paratek Pharmaceuticals, Inc.2$57
Smith+Nephew, Inc.3$56
VERTEX PHARMACEUTICALS INCORPORATED1$16

Products named: RECORLEV, GVOKE HYPOPEN, NUZYRA, COLLAGENASE SANTYL, DALVANCE, V.A.C. VERAFLO, AVYCAZ, EMBLAVEO.

Industry payments across MD — which companies pay providers there.